Review: donepezil improves cognitive and global function in people with mild to moderate Alzheimer's disease

被引：0
|
作者：
Whitehead, A. [1 ]
Perdomo, C. [1 ]
Pratt, R. D. [1 ]
机构：
[1] Univ Reading, Med & Pharmaceut Stat Res Unit, Earley Gate, Reading RG6 6FN, Berks, England
来源：
EVIDENCE-BASED MENTAL HEALTH | 2005年 / 8卷 / 01期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1136/ebmh.8.1.15
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [21] Donepezil and very mild Alzheimer's disease
    不详
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2010, 14 (01) : 30 - 30
  • [22] Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease
    Griffith, Patrick
    Lichtenberg, Peter
    Goldman, Robert
    Payne-Parrish, Jennifer
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (10) : 1590 - 1597
  • [23] Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan
    Fuh, Jong-Ling
    Wang, Shuu-Jiun
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (01) : 73 - 78
  • [24] Donepezil in the treatment of mild to moderate Alzheimer's disease: report of a Belgian multicenter study
    Santens, P
    Ventura, M
    ACTA NEUROLOGICA BELGICA, 2003, 103 (03) : 159 - 163
  • [25] Galantamine improves attention in patients with mild to moderate Alzheimer's disease
    Schwalen, S
    Vellas, B
    van Baelen, B
    Hammond, G
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S328 - S329
  • [26] Benefits of donepezil on global function, behavior, cognition, and ADLs in patients with moderate-to-severe Alzheimer's disease
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Subbiah, P
    Whalen, E
    NEUROLOGY, 2000, 54 (07) : A469 - A469
  • [27] Relationship between sarcopenic obesity and cognitive function in patients with mild to moderate Alzheimer's disease
    Weng, Xiao-fen
    Liu, Shan-wen
    Li, Meng
    Zhang, Yu
    Zhang, Ying-chun
    Liu, Chun-feng
    Zhu, Jiang-tao
    Hu, Hua
    PSYCHOGERIATRICS, 2023, : 944 - 953
  • [28] Benefits of donepezil on cognition, function and neuropsychiatric symptoms in patients with mild and moderate Alzheimer's disease over one year
    Waldemar, G
    Winblad, B
    Engedal, K
    Soininen, H
    Verhey, F
    Wimo, A
    Wetterholm, AL
    Zhang, R
    Haglund, A
    Subbiah, P
    ALZHEIMER'S DISEASE: ADVANCES IN ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 2001, : 725 - 738
  • [29] Transcranial Direct Current Stimulation Improves Cognitive Function in Mild to Moderate Alzheimer Disease A Meta-Analysis
    Cai, Mengjie
    Guo, Zhiwei
    Xing, Guoqiang
    Peng, Haitao
    Zhou, Liang
    Chen, Huaping
    McClure, Morgan A.
    He, Lin
    Xiong, Liangwen
    He, Bin
    Du, Fei
    Mu, Qiwen
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2019, 33 (02): : 170 - 178
  • [30] Functional, cognitive and behavioral benefits of donepezil inpatients with moderate Alzheimer's disease.
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Emir, B
    Subbiah, P
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S104 - S105
12345